Mark Sheptoff Financial Planning’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25
Closed -$136 – 531
2026
Q2
$136 Hold
25
– – ﹤0.01% 510
2026
Q1
$98 Hold
25
– – ﹤0.01% 504
2025
Q4
$100 Hold
25
– – ﹤0.01% 504
2025
Q3
$212 Hold
25
– – ﹤0.01% 475
2025
Q2
$282 Hold
25
– – ﹤0.01% 502
2025
Q1
$237 Hold
25
– – ﹤0.01% 437
2024
Q4
$281 Hold
25
– – ﹤0.01% 425
2024
Q3
$707 Hold
25
– – ﹤0.01% 412
2024
Q2
$478 Hold
25
– – ﹤0.01% 416
2024
Q1
$820 Buy
+25
New +$798 ﹤0.01% 380

Other funds holding EVH

Mark Sheptoff Financial Planning's EVH Position: Q3 2026 in Review

Mark Sheptoff Financial Planning sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 25 shares — an estimated $136 sold.

Mark Sheptoff Financial Planning first reported a position in EVH in Q1 2024 and held it in 10 quarters. The position peaked at $820 in Q1 2024. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Mark Sheptoff Financial Planning reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 25 Evolent Health shares in Q3 2026, an estimated $136.
  • Mark Sheptoff Financial Planning first reported a position in Evolent Health in Q1 2024 and held it in 10 quarters.
  • Mark Sheptoff Financial Planning's Evolent Health position peaked at $820 in Q1 2024.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q3 2026, filed 16 Nov 2026.